Результаты поиска - Anita K. Wagner
- Отображение 1 - 9 результаты of 9
-
1
30 years of media coverage on high drug prices in the US - a never-ending story or a time for change? по Christine Leopold, James D Chambers, Anita K Wagner
Опубликовано 2015Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
2
Integrating public preferences into national reimbursement decisions: a descriptive comparison of approaches in Belgium and New Zealand по Christine Leopold, Christine Y. Lu, Anita K. Wagner
Опубликовано 2020Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
3
Regulatory histories of recently withdrawn ovarian cancer treatment indications of 3 PARP inhibitors in the US and Europe: lessons for the accelerated approval pathway по Mahnum Shahzad, Huseyin Naci, Katharine M. Esselen, Joseph A. Dottino, Anita K. Wagner
Опубликовано 2024Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
4
1-year impact of supervision, performance assessment, and recognition strategy (SPARS) on prescribing and dispensing quality in Ugandan health facilities по Birna Trap, Moses N. Sembatya, Monica Imi, Morries Seru, Anita K. Wagner, Dennis Ross-Degnan
Опубликовано 2020Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
5
The Brazilian private pharmaceutical market after the first ten years of the generics law по Andréa Dâmaso Bertoldi, Anita K. Wagner, Isabel Cristina Martins Emmerick, Luisa Arueira Chaves, Peter Stephens, Dennis Ross-Degnan
Опубликовано 2019Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
6
Cancer drug indication approvals in China and the United States: a comparison of approval times and clinical benefit, 2001-2020Research in context по Yuxuan Wei, Yichen Zhang, Ziyue Xu, Guoan Wang, Yue Zhou, Huangqianyu Li, Luwen Shi, Huseyin Naci, Anita K. Wagner, Xiaodong Guan
Опубликовано 2024Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
7
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context по Adriana M. Ivama-Brummell, Fernanda L. Marciniuk, Anita K. Wagner, Claudia G.S. Osorio-, Sabine Vogler, Elias Mossialos, Carla L. Tavares-, Huseyin Naci
Опубликовано 2023Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
8
Effect of the economic recession on pharmaceutical policy and medicine sales in eight European countries по Christine Leopold, Aukje K Mantel-Teeuwisse, Sabine Vogler, Silvia Valkova, Kees de Joncheere, Hubert GM Leufkens, Anita K Wagner, Dennis Ross-Degnan, Richard Laing
Опубликовано 2014Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...
-
9
Access to affordable medicines after health reform: evidence from two cross-sectional surveys in Shaanxi Province, western China по Dr. Yu Fang, PhD, Anita K Wagner, DrPH, Shimin Yang, BS, Minghuan Jiang, MS, Fang Zhang, PhD, Dennis Ross-Degnan, ScD
Опубликовано 2013Шифр: Загрузка...Connect to this object online.
Местонахождение: Загрузка...